logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Harpreet Wasan

University of Hull
H指数:66
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC plus FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial

预后标志物、生活质量（QoL）和健康价值（V-He）在随机III期、多中心、开放标签的ABC-06临床试验中，接受二线单纯积极症状控制（ASC）或ASC联合奥沙利铂-5-FU化疗（ASC plus FOLFOX）治疗的晚期胆道癌（ABC）中的研究

ESMO Open
IF8.3
2026-06-010
OAAI
Lamarca, A.; Palmer, D. H.; Wasan, H. S.; Ross, P. J.; Ma, Y. T.; Arora, A.; Falk, S.; Gillmore, R.; Wadsley, J.; Patel, K.; Anthoney, A.; Maraveyas, A.; Iveson, T.; Waters, J. S.; Hobbs, C.; Macdonald, T.; Ryder, D.; Ramage, J.; Davies, L. M.; Bridgewater, J. A.; Valle, J. W.
A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3

随机对照研究：比较恩考拉非尼、西妥昔单抗和FOLFIRI方案与FOLFIRI联合或不联合贝伐珠单抗治疗BRAF V600E突变型结直肠癌——BREAKWATER队列研究3组

Annals of Oncology
IF65.4
2026-05-310
OAAI
S. Kopetz; J. Tabernero; S. Lonardi; L. Shen; H.S. Wasan; T. Yoshino; E. Van Cutsem; T.W. Kim; C. Eng; F. Ciardiello; J. Desai; T.S. Maughan; R. Yaeger; T. Usari; Xiaoxi Zhang; E. Beyzarov; A. Mori; E. Whalley; Xiaosong Zhang; E. Elez
ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine

ABC-12：探索度伐利尤单抗（MEDI4736）联合顺铂/吉西他滨一线治疗晚期胆道癌患者中的微生物组

Future Oncology
IF2.6
2025-07-290
PRE
Eleni Vrana; Hayley Timmins; Ashley Osborne; Rebecca Cox; Harpreet Wasan; Yuk Ting Ma; Arvind Arora; Olusola Faluyi; Roopinder Gillmore; Pippa Corrie; Paul Miller; Seema Arif; Joanna Canham; Charlotte Martin; Muhammad Riaz; Tongtong Shi; Melissa Frizziero; Victoria Foy; Richard A Hubner; Helen Morement; John Bridgewater; Richard Adams; Juan W Valle; Mairéad G McNamara
A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON study

BEACON研究中BRAF V600E突变型结直肠癌患者肿瘤分子变化的通俗性摘要

FUTURE ONCOLOGY
IF2.6
2025-05-090
OA
Kopetz, Scott; Murphy, Danielle A.; Pu, Jie; Ciardiello, Fortunato; Desai, Jayesh; Van Cutsem, Eric; Wasan, Harpreet Singh; Yoshino, Takayuki; Saffari, Hedieh; Zhang, Xiaosong; Hamilton, Phineas; Xie, Tao; Yaeger, Rona; Tabernero, Josep
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-09-010
PRE
Mukherjee, Somnath; Qi, Cathy; Shaw, Rachel; Jones, Christopher M.; Bridgewater, John A.; Radhakrishna, Ganesh; Patel, Neel; Holmes, Jane; Virdee, Pradeep S.; Tranter, Bethan; Parsons, Philip; Falk, Stephen; Wasan, Harpreet S.; Ajithkumar, Thankamma, V; Holyoake, Daniel; Roy, Rajarshi; Scott-Brown, Martin; Hurt, Christopher N.; O'Neill, Eric; Sebag-Montefiore, David; Maughan, Tim S.; Hawkins, Maria A.; Corrie, Pippa
Encorafenib plus cetuximab (EC) plus FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI)

Encorafenib plus cetuximab (EC) plus FOLFIRI用于BRAF V600E突变型转移性结直肠癌(mCRC)：BREAKWATER安全性导入期(SLI)的最新结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Tabernero, J.; Yoshino, T.; Kim, T. W.; Yaeger, R.; Desai, J.; Wasan, H. S.; Van Cutsem, E.; Ciardiello, F.; Maughan, T.; Eng, C.; Tie, J.; Elez Fernandez, M. E.; Lonardi, S.; Usari, T.; Hahn, E.; Dychter, S.; Ferrier, G.; Zhang, X.; Kopetz, S.
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
FUTURE ONCOLOGY
IF2.6
2024-08-081
OAAI
Harding, James J.; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Phillippe; Ying, Jie'er; Bridgewater, John; Lee, Myung-Ah; Tejani, Mohamedtaki A.; Chen, Emerson Y.; Kim, Dong Uk; Wasan, Harpreet; Ducreux, Michel; Bao, Yuanyuan; Lindsey, Stacie; Bachini, Melinda; Morement, Helen; Boyken, Lisa; Ma, Jiafang; Garfin, Phillip; Pant, Shubham
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical Trial

从结直肠癌手术到辅助化疗的时间SCOT随机临床试验的事后分析

JAMA SURGERY
IF14.9
2024-08-011
PRE
Gogenur, Mikail; Rosen, Andreas Weinberger; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; Pearson, Sarah; Boyd, Kathleen A.; Briggs, Andrew H.; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S.; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S.; Kelly, Caroline; Goegenur, Ismail; Hollaender, Niels Henrik
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials
EUROPEAN JOURNAL OF CANCER
IF7.1
2023-09-016
OAAI
Raimondi, Alessandra; Nichetti, Federico; Stahler, Arndt; Wasan, Harpreet S.; Aranda, Enrique; Randon, Giovanni; Kurreck, Annika; Meade, Angela M.; Diaz-Rubio, Eduardo; Niger, Monica; Stintzing, Sebastian; Palermo, Federica; Trarbach, Tanja; Prisciandaro, Michele; Sommerhauser, Greta; Fisher, David; Morano, Federica; Pietrantonio, Filippo; Modest, Dominik P.
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
ESMO OPEN
IF8.3
2023-06-0162
OAAI
Ducreux, M.; Abou-Alfa, G. K.; Bekaii-Saab, T.; Berlin, J.; Cervantes, A.; de Baere, T.; Eng, C.; Galle, P.; Gill, S.; Gruenberger, T.; Haustermans, K.; Lamarca, A.; Laurent-Puig, P.; Llovet, J. M.; Lordick, F.; Macarulla, T.; Mukherji, D.; Muro, K.; Obermannova, R.; O'Connor, J. -M.; O'Reilly, E. M.; Osterlund, P.; Philip, P.; Prager, G.; Ruiz-Garcia, E.; Sangro, B.; Seufferlein, T.; Tabernero, J.; Verslype, C.; Wasan, H.; Van Cutsem, E.

研究方向

暂未获取到该数据
J
John Bridgewater
H 指数:65论文数:458被引数:3.5万
J
Juan W. Valle
H 指数:87论文数:773被引数:5.0万
E
Eric Van Cutsem
H 指数:174论文数:1,832被引数:17.4万
J
Josep Tabernero
H 指数:146论文数:2,711被引数:12.7万
D
David Cunningham
H 指数:153论文数:2,060被引数:13.0万
J
Jayesh Desai
H 指数:67论文数:651被引数:2.9万
F
Fortunato Ciardiello
H 指数:107论文数:1,034被引数:6.4万
A
Andre Lopes
H 指数:26论文数:95被引数:3,972
P
Paul J. Ross
H 指数:61论文数:397被引数:2.3万
S
Scott Kopetz
H 指数:109论文数:1,942被引数:5.8万